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httpIntrathoracic subclavian artery aneurysm repair
in the thoracic endovascular aortic repair era
Nicholas D. Andersen, MD,a Michael E. Barﬁeld, MD,a,b Jennifer M. Hanna, MD, MBA,a
Asad A. Shah, MD,a Cynthia K. Shortell, MD,b Richard L. McCann, MD,b and
G. Chad Hughes, MD,a Durham, NC
Objective: Intrathoracic subclavian artery aneurysms (SAAs) are rare aneurysms that often occur in association with
congenital aortic arch anomalies and/or concomitant thoracic aortic pathology. The advent of thoracic endovascular
aortic repair (TEVAR) methods may complement or replace conventional open SAA repair. Herein, we describe our
experience with SAA repair in the TEVAR era.
Methods: A retrospective review was performed of all intrathoracic SAAs repaired at a single institution since United States
Food and Drug Administration approval of TEVAR in 2005.
Results: Nineteen patients underwent 20 operations to repair 22 (13 native, nine aberrant) SAAs with an intrathoracic
component. Mean SAA diameter was 3.1 cm (range, 1.6-6.0 cm). Mean patient age was 57 years (range, 24-80 years).
Twenty-one percent (n [ 4) of patients had a connective tissue disorder (two Loeys-Dietz, two Marfan). Thirty-six
percent (n [ 8) of SAAs were repaired by open techniques and 64% (n [ 14) via a TEVAR-based approach. All
TEVAR cases required proximal landing zone in the aortic arch (zone 0-2), and revascularization of at least one arch
vessel was required in 83% (10/12) of patients. Concomitant repair of associated aortic pathology was performed in 50%
(n [ 10) of operations. Thirty-day/in-hospital rates of death, stroke, and permanent paraplegia/paraparesis were 5%
(n[ 1), 5% (n[ 1), and 0%, respectively. Over mean (standard deviation) follow-up of 24 (21) months, 16% (n[ 3) of
patients required reintervention for subclavian artery bypass graft revision (n [ 2) or type II endoleak (n [ 1).
Conclusions: This is the largest single-institution series to date of TEVAR for SAA repair. Modern endovascular
techniques expand SAA repair options with excellent results. The majority of SAAs and nearly all aberrant SAAs
(Kommerell’s diverticulum) can now be repaired using a TEVAR-based approach without the need for sternotomy or
thoracotomy. (J Vasc Surg 2013;57:915-25.)Intrathoracic subclavian artery aneurysms (SAAs) are
rare peripheral arterial aneurysms that are repaired to prevent
rupture or treat symptoms of thrombosis, embolization, pain,
or local compression.1 The surgical approach to SAA repair is
often complex and is challenged by the presence of congen-
ital aortic arch anomalies, concomitant aortic pathology,
prior aortic interventions, patient comorbid conditions,
and/or hereditary connective tissue disease (CTD).2
Conventional open SAA repair requires sternotomy
or thoracotomy for access and in a recent meta-analysis
was associated with a mortality rate of 8% and a complica-
tion rate of 26%.1 In the present era, many SAAs can be
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with reduced morbidity.1
The availability of thoracic endovascular aortic repair
(TEVAR) in 2005 provided an additional tool for the treat-
ment of complex thoracic aortic pathology. Reports of
TEVAR for SAA repair are limited to case reports,3-19
and no single-institution series has speciﬁcally explored
the role of TEVAR for SAA repair. We therefore sought
to review our institutional experience with SAA repair since
United States Food and Drug Administration approval of
TEVAR in March 2005 and present our surgical approach
to SAA repair using both open and TEVAR-based endo-
vascular techniques.
METHODS
Patient population and data collection. The Institu-
tional Review Board of Duke University approved this
study, and the need for individual patient consent was
waived. The Duke Thoracic Aortic Surgery Database is
a prospectively maintained electronic clinical registry of
all patients who have undergone thoracic aortic surgery
at Duke University Medical Center (Durham, NC) since
2005.20,21 Between March 2005 and April 2012, 19
patients underwent 20 operations to repair 22 (13 native,
nine aberrant) SAAs with an intrathoracic component and
form the basis of this report.
In this article, the term “native” is used to refer to a non-
aberrant subclavian artery arising from the normal anatomic
position on the aortic arch. Aortic arch landing zones915
Fig 1. Native left subclavian artery aneurysm (SAA) endovascular repair. A, Preoperative appearance of the aneurysmal
left subclavian artery (LSCA) with a concomitant descending thoracic aortic aneurysm. B, Repair is accomplished by
endovascular coverage of the LSCA oriﬁce and distal vascular plug occlusion proximal to the origin of the left vertebral
artery. In the case shown, the thoracic endograft was used to treat a concomitant descending thoracic aortic aneurysm.
C, The LSCA was revascularized selectively via a left carotid–subclavian bypass for previously reported indications.20
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conditions and postoperative complications were deﬁned
using Society of Thoracic Surgeons deﬁnitions (www.sts.
org). Indications for SAA repair included size >2.0 cm,
symptoms, or size >1.5 cm and concurrent operation for
other aortic pathology. Open proximal thoracic aortic
operations were performed as previously described.23-25
Techniques of TEVAR device delivery and deployment
and of postoperative surveillance have been described
previously.21,26,27 All thoracic endografts commercially
available during the study period were used and included
the Gore TAG and C-TAG (W. L. Gore & Associates, Flag-
staff, Ariz), Medtronic Talent (Medtronic Inc, Santa Rosa,
Calif), and Zenith TX2 (Cook Medical Inc, Bloomington,
Ind) devices. Primary technical success was deﬁned accord-
ing to Society for Vascular Surgery reporting standards.28
Patient survival and subclavian artery bypass graft
patency were assessed from the electronic medical record.
Subclavian artery bypass graft patency at most recent
follow-up was determined based on imaging ﬁndings.
Life status was assessed for patients lost to follow-up using
the Social Security Death Database.
Statistical analysis. Continuous and categorical vari-
ables were compared between groups using the Mann-
Whitney test and the c2 test, respectively. Estimates of
subclavian artery bypass graft patency and reintervention
rates were calculated using the Kaplan-Meier method using
the date of the most recent clinic visit with computed
tomographic angiography to deﬁne the follow-up interval.
Survival rates were calculated using the Kaplan-Meier
method. Patients were presumed to be living unless
medical record or the Social Security Death Database
conﬁrmed death. Calculations were performed using SPSS
19.0.0 (IBM SPSS Statistics, Chicago, Ill).
Operative techniques
Native left SAA repair—endovascular approach. An
endovascular approach was used in patients with a nativeleft SAA without concomitant aortic pathology requiring
open repair (Fig 1). Selective left subclavian artery (LSCA)
revascularization (8-mm polytetraﬂuoroethylene graft)
was performed at the time of the TEVAR procedure based
on previously established indications and institutional
protocols.20 Proximal exclusion of the LSCA was accom-
plished by deployment of the aortic endograft with LSCA
coverage. Distal SAA exclusion was accomplished by liga-
tion, coil embolization, or placement of an Amplatzer
Vascular Plug (St. Jude Medical Inc, St. Paul, Minn) via
left brachial access.
Native left SAA repair—open approach. Open left
SAA repair was reserved primarily for patients requiring
concomitant extensive aortic replacement due to CTD
or “mega aorta syndrome.”29,30 In all cases except one,
a total arch replacement (stage I elephant trunk procedure)
was performed ﬁrst using a modiﬁed Mt. Sinai tech-
nique.25,30 If the LSCA arose proximally enough from the
aortic arch such that it could be reached via sternotomy, then
the aneurysmal LSCA was ligated and bypassed during total
arch replacement (Fig 2, A). In patients in whom the LSCA
arose too distally from the arch to be addressed via ster-
notomy, the left SAA was excluded by descending aorta to
LSCA bypass at the time of open stage II thoracoabdominal
aortic aneurysm (TAAA) repair (Fig 2, B and C).31
Aberrant left SAA repair. The aberrant left SAAs
(Kommerell’s diverticulum) in this series occurred in
patients with right-sided aortic arches and right descend-
ing thoracic aortas and were treated by endovascular
methods. Proximal exclusion of the aberrant LSCA was
accomplished by endograft coverage of the LSCA oriﬁce.
Distal SAA exclusion was accomplished by coil embolization
or vascular plug occlusion via left brachial access (Fig 3).
Native right SAA repair. The native right SAAs
encountered in this series did not involve the innominate
artery and were repaired by open bypass at the time of
concurrent arch repair or interposition grafting via median
sternotomy (Fig 4).
Fig 2. Native left subclavian artery aneurysm (SAA) open repair. For patients with a native left SAA and extensive
thoracic aortic disease, total arch replacement (stage I elephant trunk procedure) was ﬁrst performed using a modiﬁed
Mt. Sinai technique.25,30 A, For patients in whom the left subclavian artery (LSCA) was accessible via a median
sternotomy approach, the LSCA was ligated and bypassed at the time of total arch replacement. B and C, For patients
in whom the LSCA was not accessible via median sternotomy, the LSCA was bypassed from the new Dacron
descending aorta at the time of open stage II thoracoabdominal aortic aneurysm (TAAA) repair.
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(Kommerell’s diverticulum) were repaired using endo-
vascular methods (Fig 5). Given the proximity of the aber-
rant right subclavian artery (RSCA) to the other arch
vessels, isolated endograft coverage of the RSCA oriﬁce was
not possible, and zone 2–zone 0 endograft coverage was
required to achieve adequate proximal landing zone,
yielding bilateral subclavian artery coverage in all cases. As
such, at least one subclavian artery was revascularized in all
cases, and bilateral subclavian artery revascularization was
performed if indicated.20 For cases requiring zone 1
endograft coverage, a carotid–carotid bypass was performed
to revascularize the left common carotid artery (LCCA)
before LCCA coverage by the endograft. For cases re-
quiring zone 0 endograft coverage, ascending aorta-based
arch debranching was performed via median sternotomy to
revascularize the right common carotid artery (RCCA)
and LCCA before endograft coverage.25,30RESULTS
Patient demographics are listed in Table I. Operative
characteristics for SAA repair stratiﬁed by anatomic
subtype are given in Tables II-V. Thirty-day/in-hospital
outcomes are listed in Table VI. Kaplan-Meier estimatesof reinterventions, primary subclavian artery bypass graft
patency, and survival are shown in Fig 6.
Operative details
Native left SAA repair—endovascular approach.
Five patients underwent native left SAA repair via a totally
endovascular or hybrid approach (Table II). Repair was
achieved exclusively by endovascular methods in one patient
(no. 1) by LSCA endograft coverage and endovascular distal
aneurysm occlusion (Fig 1, B). Repair was achieved by the
same method in a second patient (no. 2), but LSCA revas-
cularization was required due to symptoms of arm ischemia
after endograft deployment (Fig 1, C). The third patient
(no. 3) underwent vascular plug occlusion of a left SAA,
followed by proximal LSCA endovascular coverage 9
months later at the time of hybrid TAAA repair for a rapidly
enlarging TAAA.32
The remaining two patients (no. 4 and 5) had bilateral
SAAs (native left SAA and aberrant right SAA) that were
repaired by endograft coverage of the two neighboring
subclavian arteries (Fig 5, B and C). Patient no. 4 had
previously undergone aberrant right SAA distal ligation
with RCCA to RSCA bypass at an outside institution,
although the residual aberrant right SAA stump continued
to be pressurized, via the vessel origin from the aorta, and
Fig 3. Aberrant left subclavian artery aneurysm (SAA; Kommerell’s diverticulum) repair. A, Preoperative appearance of
an aberrant left SAA in a patient with a right-sided aortic arch and a right descending thoracic aorta. B, Repair is
accomplished by endovascular coverage of the left subclavian artery (LSCA) oriﬁce and vascular plug occlusion distal to
the aneurysm. In the case shown, coverage of the right subclavian artery (RSCA) or more proximal arch vessels was not
required, although this may be necessary in some cases.
Fig 4. Native right subclavian artery aneurysm (SAA) repair. A, Preoperative appearance of a proximal native right
SAA. B, In the case shown, repair was accomplished by right subclavian artery (RSCA) interposition grafting with
aneurysm exclusion (endoaneurysmorrhaphy).
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patient to preserve unilateral vertebral artery perfusion
given that the right vertebral artery had been sacriﬁced
during the previous RSCA ligation. This patient also
harbored a 5.1-cm proximal descending thoracic aortic
aneurysm that was excluded by the endograft. Patient no.
5 underwent aberrant right SAA repair by endograft
coverage and vascular plug occlusion, and later underwent
native left SAA repair by placement of a proximal extension
cuff and LSCA vascular plug during a second procedure
given interval left SAA growth.
Native left SAA—open approach. Six patients under-
went open repair of a native left SAA (Table II). The ﬁrstpatient (no. 6) had Marfan syndrome with bilateral native
right and left SAAs. He had previously undergone aortic
root replacement for type A dissection and later open
extent II TAAA repair. The bilateral SAAs were ligated
and bypassed at the time of open total arch replacement to
repair a coexisting 5.3-cm transverse arch aneurysm. The
second patient (no. 7) had mega aorta syndrome with
concurrent ascending, arch, and TAAAs, in addition to
a symptomatic left SAA.He underwent left SAA ligation and
bypass at the time of valve-sparing aortic root and total aortic
arch replacement and later underwent hybrid TAAA
repair including visceral debranching and stented elephant
trunk to complete the treatment of his aortic pathology
Fig 5. Aberrant right subclavian artery aneurysm (SAA; Kommerell’s diverticulum) repair. A, Preoperative appearance
of an aberrant right SAA with a concomitant descending thoracic aortic aneurysm. B, In the ﬁrst scenario, repair was
achieved via zone 2 endograft placement with bilateral subclavian artery (SCA) coverage and vascular plug occlusion of
the aneurysm outﬂow. A left carotid–subclavian bypass was performed to revascularize at least one subclavian artery. C,
In the second scenario, zone 1 endograft placement was required to achieve adequate proximal seal, necessitating
carotid–carotid bypass for left common carotid artery (LCCA) revascularization in addition to left subclavian artery
(LSCA) revascularization.
Table I. Baseline characteristics
Variable
Total SAA patients
(n ¼ 19)a
Native left
(n ¼ 11)
Aberrant left
(n ¼ 2)
Native right
(n ¼ 2)
Aberrant right
(n ¼ 7)
Age, years 57 (24-80) 55 (24-80) 53 (37-69) 45 (40-50) 69 (48-79)
Male gender 9 (47%) 6 (55%) 0 2 (100%) 3 (43%)
Hypertension 11 (58%) 6 (55%) 1 (50%) 2 (100%) 4 (57%)
Tobacco use 9 (47%) 5 (45%) 0 2 (100%) 3 (43%)
Baseline creatinine >1.5 mg/dL 2 (11%) 2 (18%) 0 0 1 (14%)
Peripheral vascular disease 3 (27%) 2 (18%) 0 0 1 (14%)
Connective tissue disease 4 (21%) 4 (36%) 0 1 (50%) 0
Previous aortic surgery 10 (53%) 7 (64%) 0 2 (100%) 4 (57%)
Symptomatic SAAs 7 of 22 (32%) 3 (27%) 2 (100%) 1 (50%) 1 (14%)
Urgent/emergent operation 3 of 20 (15%) 0 1 (50%) 0 2 (29%)
Aneurysm diameter, cm 3.1 (1.6-6) 3.1 (2-5.7) 2.4 (2-2.8) 3.2 (3-3.3) 3.4 (1.6-6)
Data are given as mean (range) or number (percent).
aCumulative values for the cohort of 19 patients who underwent 22 subclavian artery aneurysm (SAA) repairs during 20 operations.
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underwent left SAA resection and bypass via left thora-
cotomy at the time of open TAAA repair after stage I total
arch replacement. In all of these patients, theLSCA arose too
far distally on the aortic arch to be addressed via median
sternotomy at the time of the ﬁrst stage total arch replace-
ment (Fig 2, B). The ﬁnal patient (no. 11) presented with
complete thrombosis of a native left SAA leading to left hand
emboli and ischemia. She underwent openLCCA to brachial
artery bypass with distal aneurysm ligation to exclude the
aneurysm and revascularize the left upper extremity.
Aberrant left SAA. Two patients underwent aberrant
left SAA (Kommerell’s diverticulum) repair via a totally
endovascular or hybrid approach (Table III). The ﬁrst
patient (no. 12) underwent urgent total endovascular
repair of a symptomatic aberrant left SAA by LSCA coverage
and distal plug occlusion without LSCA revascularization
(Fig 3, B). The second patient (no. 13) required a zone0 ascending aorta proximal landing zone to obtain ade-
quate proximal seal, which was performed via median
sternotomy for ascending aorta to LCCA, RCCA, and
left axillary bypass using a trifurcated graft.
Native right SAA. Two patients underwent open
repair of a native right SAA (Table IV). The ﬁrst was the
aforementioned patient (no. 6) with Marfan syndrome
who had bilateral native SAAs that were repaired by ligation
and bypass during total arch replacement. The second
patient (no. 14) underwent median sternotomy and RSCA
interposition grafting with an 8-mm polyester (Dacron)
graft (endoaneurysmorrhaphy; Fig 4, B).
Aberrant right SAA. Seven patients underwent
aberrant right SAA (Kommerell’s diverticulum) repair via
a totally endovascular or hybrid approach (Table V). The
ﬁrst two were the aforementioned patients (no. 4 and 5)
with bilateral native left and aberrant right SAAs that
were repaired by endograft coverage of the neighboring
Table II. Native left subclavian artery aneurysm repairs
Patient
SAA
size, cm CTD Symptoms
Concomitant
aortic pathology
Open
procedure
Endovascular
procedure
Aneurysm
exclusion SCA bypass
F/U,
months
1 2 — L hand emboli — — Zone 2 TEVAR Amplatzer plug — 23
2 6 — — — — Zone 2 TEVAR Coil
embolization
LCCA to LSCA 15
3 2.6 — — TAAA Visceral
debranching
Hybrid TAAA
repair with
zone 2
TEVAR
Amplatzer plug LCCA to LSCA 20
4L 3 — — Descending
TAA
Carotide
carotid
bypass
Zone 1 TEVAR Ligation LCCA to L
axillary artery
11
5L 5.7 — — — — Zone 2 TEVAR Amplatzer plug LCCA to LSCA 17
6L 2.4 MF — Transverse arch
aneurysm
Total
arch repair
— Ligation LCCA to L
axillary artery
33
7 2 — L hand emboli Mega aorta
syndrome
VSRR þ total
arch repair
— Ligation LCCA to L
axillary artery
33
8 2.2 LDS — TAAA S/P
stage I total
arch repair
Open TAAA
repair
— Resection Descending
aorta to
LSCA
58
9 3 LDS — TAAA S/P
stage I total
arch repair
Open TAAA
repair
— Resection Descending
aorta to
LSCA
13
10 2 MF — TAAA s/p
stage I total
arch repair
Open TAAA
repair
— Resection Descending
aorta to
LSCA
9
11 2.5 — L hand emboli
and ischemia
— Open bypass — Ligation LCCA to L
brachial
artery
12
CTD, Connective tissue disease; F/U, follow-up; L, left; LCCA, left common carotid artery; LDS, Loeys-Dietz syndrome; LSCA, left subclavian artery; MF,
Marfan syndrome; SAA, subclavian artery aneurysm; SCA, subclavian artery; S/P, status post; TAA, thoracic aortic aneurysm; TAAA, thoracoabdominal aortic
aneurysm; TEVAR, thoracic endovascular aortic repair; VSRR, valve-sparing root replacement.
Table III. Aberrant left subclavian artery aneurysm (Kommerell’s diverticulum) repairs
Patient
SAA
size, cm CTD Symptoms
Concomitant
aortic pathology
Open
procedure
Endovascular
procedure
Aneurysm
exclusion SCA bypass
F/U,
months
12 2 — Chest pain — — Zone 2 TEVAR Amplatzer plug — 28
13 2.8 — Chest pain — Arch
debranching
Zone 0 TEVAR Coil
embolization
Ascending aorta
to L axillary
artery
1
CTD, Connective tissue disease; F/U, follow-up; L, left; SAA, subclavian artery aneurysm; SCA, subclavian artery; TEVAR, thoracic endovascular aortic repair.
JOURNAL OF VASCULAR SURGERY
920 Andersen et al April 2013subclavian arteries (Fig 5, B and C). RSCA revasculariza-
tion was previously performed in the ﬁrst patient (no. 4)
and was not necessary in the second patient (no. 5) given
LCCA to LSCA bypass in the setting of bilateral subclavian
artery endograft coverage.
One patient (no. 15) experienced an acute type B
aortic dissection with contained rupture and extension of
the dissection into an aneurysmal aberrant right SAA. He
required bilateral subclavian artery coverage to cover the
primary dissection tear and later underwent open aberrantright SAA ligation because of type II endoleak, and bilat-
eral carotid–subclavian bypass because of symptoms of ver-
tebrobasilar insufﬁciency.
One additional patient (no. 16) required zone 1
endograft placement to achieve proximal seal (Fig 5, C),
and two patients required zone 0 endograft coverage in
order to treat concurrent transverse arch pathology
(no. 17) or achieve adequate proximal seal (no. 18).
Urgent repair was required in the latter patient (no. 18)
due to aberrant right SAA erosion into the posterior
Table IV. Native right subclavian artery aneurysm repairs
Patient
SAA
size, cm CTD Symptoms
Concomitant
aortic pathology Open procedure
Endovascular
procedure
Aneurysm
exclusion SCA bypass
F/U,
months
6R 3.3 MF — Transverse arch
aneurysm
Total
arch repair
— — RSCA to
R brachial
artery
33
14 3 — Chest pain — RSCA interposition
graft
— Endoaneurys-
morrhaphy
RSCA
interposition
77
CTD, Connective tissue disease; F/U, follow-up; MF, Marfan syndrome; R, right; RSCA, right subclavian artery; SAA, subclavian artery aneurysm; SCA,
subclavian artery.
Table V. Aberrant right subclavian artery aneurysm (Kommerell’s diverticulum) repairs
Patient
SAA
size, cm CTD Symptoms
Concomitant
aortic pathology Open procedure
Endovascular
procedure
Aneurysm
exclusion SCA bypass
F/U,
months
4R 3.3 — — Descending
TAA
Carotidecarotid
bypass
Zone 1 TEVAR Prior
ligation
Prior RCCA to
RSCA bypass
11
5R 4.4 — — — — Zone 2 TEVAR Amplatzer
plug
— 28
15 2 — — Ruptured acute
type B dissection
— Zone 2 TEVAR Ligation RCCA to
RSCA and
LCCA to LSCA
72
16 2.8 — — — Carotidecarotid
bypass
Zone 1 TEVAR — LCCA to LSCA 25
17 1.6 — — Transverse
arch aneurysm
Arch debranching Zone 0 TEVAR — Ascending aorta
to LSCA
7
18 6 — Aberrant R
SAA to
esophageal
ﬁstula
— Arch debranching Zone 0 TEVAR Ligation Ascending aorta
to LSCA and
RCCA to R
axillary artery
1
19 3.6 — — Mega aorta
syndrome S/P
stage I total arch
repair
Visceral
debranching
Hybrid TAAA þ
stented elephant
trunk
Amplatzer
plug
— 2
CTD, Connective tissue disease; F/U, follow-up; LCCA, left common carotid artery; LSCA, left subclavian artery; R, right; RCCA, right common carotid
artery; RSCA, right subclavian artery; SAA, subclavian artery aneurysm; SCA, subclavian artery; S/P, status post; TAA, thoracic aortic aneurysm; TAAA,
thoracoabdominal aortic aneurysm; TEVAR, thoracic endovascular aortic repair.
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to evidence of arm ischemia after endograft deployment.
The ﬁnal patient (no. 19) had mega aorta syndrome
and had previously undergone total arch replacement
(stage I elephant trunk procedure) at an outside hospital.
The great vessels off of the arch were implanted into the
Dacron arch graft using an island technique. The patient
underwent a visceral debranching hybrid TAAA repair 5
years later at our institution, with proximal landing zone
in the elephant trunk graft. The aberrant right SAA arising
from the proximal descending thoracic aorta was excluded
by completion endografting and distal vascular plug occlu-
sion (Fig 7).
Thirty-day/in-hospital outcomes. All patients sur-
vived to hospital discharge. One patient (no. 18) died after
hospital discharge but within 30 days of surgery due to
respiratory failure after urgent zone 0 hybrid arch repair,yielding a 30-day/in-hospital mortality rate of 5% (0%
elective, 33% nonelective). One patient with an aberrant
left SAA and right descending thoracic aorta (no. 13)
experienced a perioperative stroke, and no cases of para-
plegia were observed (Table VI).
Subclavian artery bypass graft patency, reinterven-
tions, and survival. Mean clinic follow-up was 24 (21)
months (median, 18 months) with 21% (4/19) of
patients lost to follow-up. During the follow-up interval,
16% (n ¼ 3) of patients required reintervention (Fig 6,
A). Both patients with native right SAAs required rein-
tervention. The ﬁrst patient (no. 6) experienced acute
thrombosis of the RSCA to right brachial artery bypass
graft on postoperative day 12 and required a Fogarty
thrombectomy. The second patient (no. 14) experienced
RSCA interposition graft thrombosis 6 months after
repair and underwent RCCA to right axillary bypass with
Table VI. Thirty-day/in-hospital outcomes
Variable
Total procedures
(n ¼ 20)
Hybrid/endovascular
(n ¼ 13) Open (n ¼ 7) P value
In-hospital death 0 0 0
Thirty-day/in-hospital death 1 (5%) 1 (7.7%) 0 >.99
Stroke (neurologic deﬁcit lasting >72 hours) 1 (5%) 1 (7.7%) 0 >.99
Permanent paraplegia/paraparesis 0 0 0
Data are given as number (percent).
Fig 6. Kaplan-Meier estimates of freedom from reintervention (A), primary subclavian artery bypass graft patency (B),
and survival (C), stratiﬁed by operative approach. Asterisk denotes the time point at which standard error exceeds 10%.
N, Number at risk; SE, standard error; TEVAR, thoracic endovascular aortic repair.
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underwent aberrant RSCA ligation for type II endoleak 6
weeks after emergent acute type B dissection and aberrant
right SAA repair. Primary subclavian artery bypass graft
patency at 12 months was 100% for TEVAR-based repairs
but 75% for open repairs due to the two failed RSCA
bypass grafts that required reintervention (P ¼ .11; Fig 6,
B). Secondary patency was 100% as all subclavian arterybypass grafts were patent at most recent follow-up.
Kaplan-Meier estimates of survival for the entire patient
cohort were 95% and 73% at 1 and 3 years, respectively
(P ¼ .59; Fig 6, C).
DISCUSSION
In this study, we detail our recent experience with SAA
repair since the advent of TEVAR using open, totally
Fig 7. Treatment of mega aorta syndrome with an aberrant right subclavian artery aneurysm (SAA). A, The patient
(no. 19) underwent stented elephant trunk with visceral debranching hybrid thoracoabdominal aortic aneurysm
(TAAA) repair 5 years after total arch replacement (stage I elephant trunk procedure) at an outside hospital. B, The
aberrant right SAA arising from the proximal descending thoracic aorta was excluded by proximal endografting and
distal occlusion with an Amplatzer Vascular Plug II (AVP II; arrow).
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of 19 patients with 22 SAAs represents one of the largest
single-institution reports of SAA repair in the literature
and the largest series of patients with SAA to be treated
using TEVAR.1 In total, 36% (n ¼ 8) of SAAs were
repaired by open techniques and 64% (n ¼ 14) were
repaired via a TEVAR-based approach. Of the 12 patients
with 14 SAAs repaired by TEVAR, repair was achieved by
totally endovascular techniques in 17% (n ¼ 2) of patients
and by hybrid techniques in 83% (n ¼ 10) of patients. The
outcomes of SAA repair appeared favorable and were
comparable with prior reports.1
SAAs are rare entities that comprise 0.5% of all aneu-
rysm repairs in the United States.34 However, SAAs are
perhaps 200 to 3000 times more likely to occur in patients
with other peripheral aneurysms or aortic pathology. Dent
et al35 reported SAA repairs were performed in 0.0007%
(2/287,448) of individuals in the general hospital popula-
tion but in 0.13% (2/1488) of individuals with aortoiliac
or peripheral arterial aneurysms.35 The current report
suggests an even stronger association between SAAs and
thoracic aortic disease. At our institution, 925 patients
have undergone one or more thoracic aortic operations
since 2005, and 19 of these patients harbored an SAA
meeting criteria for repair, yielding an incidence of SAA
repair of 2.1% in individuals with thoracic aortic pathology
requiring surgical repair. In addition, 53% (10/19) of SAA
patients in the present series had a history of prior aorticsurgery, and 53% (10/19) underwent repair of concomitant
thoracic aortic pathology at the time of SAA repair. Thus,
practitioners of aortic and vascular surgery should expect
to encounter SAAs with some frequency and be familiar
with the treatment options for these lesions.
Aneurysmal degeneration of an aberrant subclavian
artery was ﬁrst described by Burckhard F. Kommerell in
1936 and is commonly referred to as “Kommerell’s diver-
ticulum.”36 An aberrant RSCA arising from a left-sided
aortic arch occurs in 0.5% of the population and is the
most common congenital anomaly of the aortic arch.37
An aberrant LSCA arising from a right-sided aortic arch
is 10 times less common and occurs in 0.05% to 0.1% of
the population.38 Reports of aberrant SAAs are restricted
largely to case reports or small case series.37-39 However,
aberrant SAAs may be more unstable than native SAAs
and were associated with a 19% to 53% rate of rupture or
dissection in prior comprehensive reviews.37,40 Aberrant
SAAs are well suited to repair by TEVAR as the aneurysmal
aberrant subclavian artery is the most distal branch vessel of
the aortic arch. Of note, all aberrant SAAs in this series
were treated by endovascular methods due to this favorable
anatomic conﬁguration. In the setting of an aberrant SAA
with a concomitant native SAA, the aberrant and native
subclavian arteries neighbor each other on the aorta and
are easily treated by bilateral subclavian artery coverage
with a single endograft. The TEVAR procedure has previ-
ously been used to repair at least nine aberrant SAAs.10-19
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experience of TEVAR for repair of Kommerell’s divertic-
ulum and adds another nine cases to the medical literature.
SAAs are repaired to prevent rupture or treat symptoms
of thrombosis, embolization, pain, or local compression. A
meta-analysis of 394 native SAAs found that symptoms
were present in 84% of patients, with local pain/pulsation,
compression of neighboring structures, embolization,
rupture, and thrombosis being the most common present-
ing symptoms, in order of decreasing frequency. Rupture
occurred in 9% of patients and carried a mortality rate of
19%. However, the authors were unable to identify a size
threshold that was predictive of rupture. In addition,
thrombosis was found to occur in smaller SAAs, ranging
between 1.2 and 2.5 cm in size. In 2004, Cina et al40
reviewed all cases of aberrant SAAs occurring with
a right-sided aortic arch and found that rupture occurred
in SAAs ranging between 2 and 10 cm in size (average
5.8 [2] cm). The authors recommended SAA repair at
a size of 3.0 cm; however, this recommendation was based
only on the opinion that SAAs are easier to repair when
they are small and was not based on statistical analysis.40
Alternatively, Coselli and Crawford2 recommended SAA
repair whenever feasible, regardless of size, given the high
rate of complications. In the present series, we elected to
repair SAAs when patients were symptomatic, when
patients required operation for other aortic pathology, or
when SAA size was >2.0 cm given the unpredictable
natural history of SAAs and the documented risk of rupture
and thrombosis at this size.
Despite the availability of endovascular repair methods,
seven patients with eight SAAs were selected for conven-
tional open repair. Open SAA repair was ﬁrst attempted
unsuccessfully by Mott in 1818 by innominate artery liga-
tion and later successfully by Smyth in 1864 and by Halsted
in 1892.36 Before the endovascular era, contemporary
open SAA repair required sternotomy or thoracotomy for
access together with cardiopulmonary bypass and hypo-
thermic circulatory arrest in many cases.1,2,37 The most
important factors necessitating open repair in the present
series included extensive thoracic aortic disease requiring
concomitant open repair, CTD, or SAA anatomy not
amenable to an endovascular approach. The incidence of
SAA may be higher in patients with CTD as it was previ-
ously shown that 10% of SAA repairs occurred in patients
with CTD.41 In the present series, 21% of SAA patients
had CTD, and 4 of 45 patients with a conﬁrmed diagnosis
of CTD undergoing thoracic aortic surgery at our institu-
tion during the study period harbored an SAA, for an over-
all incidence of 9% in this patient population. Failure of
endovascular therapy is common in patients with CTD,
and we continue to recommend open aneurysm repair
whenever feasible in these patients.42
Endovascular SAA repair has been shown to be associ-
ated with a lower rate of cardiopulmonary complications.1
However, stent grafting within the subclavian artery to
exclude SAAs with covered stents has been associated
with high rates of short-term thrombosis and failure(0% to 17%) due to compression, deformation, and fracture
as a result of the rotationary forces experienced by the
subclavian artery and the anatomic location under the clav-
icle.1,36 Proximal SAA inﬂow exclusion by aortic endograft-
ing may therefore be a superior method of endovascular
SAA treatment by avoiding the limitations of stent graft
placement within the subclavian artery. The present report
appears to support this approach by demonstrating a 100%
primary technical success rate, 100% primary subclavian
artery bypass graft patency, and 91% freedom from reinter-
vention rate with TEVAR-based endovascular repair
techniques.
Study limitations. Reports of SAA repair are typically
restricted to case reports or small case series. Despite the
relatively large patient cohort in the present study, it
remains limited by the constraints of sample size, which
limits the comparison of ﬁndings between procedures as
well as with other published reports. In addition, the oper-
ations were performed by two principal co-surgeons using
standardized techniques, and results may not be generaliz-
able to other practitioners treating different patient popula-
tions in different arenas.
CONCLUSIONS
SAAs are rare vascular lesions that require complex
operative planning due to numerous anatomic and patient-
speciﬁc considerations. Modern TEVAR-based endovas-
cular techniques expand SAA repair options with excellent
results and allow for less invasive repair of SAAs as well as
concomitant thoracic aortic pathology in many patients.
The majority of SAAs, and nearly all aberrant SAAs, can
now be repaired using a TEVAR-based approach without
the need for sternotomy or thoracotomy.AUTHOR CONTRIBUTIONS
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